Lanlin Hu

443 total citations
20 papers, 250 citations indexed

About

Lanlin Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lanlin Hu has authored 20 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Lanlin Hu's work include Ferroptosis and cancer prognosis (4 papers), Immune Cell Function and Interaction (3 papers) and RNA modifications and cancer (3 papers). Lanlin Hu is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Immune Cell Function and Interaction (3 papers) and RNA modifications and cancer (3 papers). Lanlin Hu collaborates with scholars based in China, United States and Canada. Lanlin Hu's co-authors include Gabrielle L. Boulianne, Peter Falkai, William G. Honer, William S. Trimble, Clint Young, Jennifer Bonner, Zhichao Luo, Chuan Xu, Fangdong Zou and Yunchang Li and has published in prestigious journals such as Journal of Biological Chemistry, Environmental Health Perspectives and International Journal of Molecular Sciences.

In The Last Decade

Lanlin Hu

16 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlin Hu China 9 130 86 47 41 32 20 250
Birgit Nimmervoll United States 9 151 1.2× 83 1.0× 52 1.1× 30 0.7× 48 1.5× 10 323
Simon April-Monn Switzerland 6 145 1.1× 88 1.0× 22 0.5× 63 1.5× 36 1.1× 8 364
John R. Jacob United Kingdom 10 199 1.5× 39 0.5× 34 0.7× 45 1.1× 56 1.8× 21 321
Hyun–Taek Kim South Korea 7 157 1.2× 90 1.0× 79 1.7× 18 0.4× 34 1.1× 8 313
Carmela Gómez Spain 14 164 1.3× 115 1.3× 18 0.4× 37 0.9× 26 0.8× 26 391
Fernando C. Alsina Argentina 9 161 1.2× 102 1.2× 19 0.4× 18 0.4× 33 1.0× 12 303
Razina Aziz‐Bose United States 7 175 1.3× 66 0.8× 51 1.1× 15 0.4× 19 0.6× 10 306
Yasuharu Takamori Japan 10 175 1.3× 108 1.3× 31 0.7× 13 0.3× 38 1.2× 22 384
Ilona Kondratiuk Poland 9 207 1.6× 51 0.6× 87 1.9× 68 1.7× 20 0.6× 9 329
Yi Tan China 6 330 2.5× 105 1.2× 26 0.6× 52 1.3× 24 0.8× 14 479

Countries citing papers authored by Lanlin Hu

Since Specialization
Citations

This map shows the geographic impact of Lanlin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlin Hu more than expected).

Fields of papers citing papers by Lanlin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlin Hu. The network helps show where Lanlin Hu may publish in the future.

Co-authorship network of co-authors of Lanlin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlin Hu. A scholar is included among the top collaborators of Lanlin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlin Hu. Lanlin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yong, Ruimin Tang, Lanlin Hu, et al.. (2025). The YAP1/GPX4 axis alleviates osteoporosis by affecting ferroptosis in osteoblasts. Molecular Medicine. 31(1). 315–315.
2.
Wang, Dandan, Zhexuan Li, Lanlin Hu, et al.. (2025). Squamous cell carcinoma of the small intestine: a case report and review of literature. Frontiers in Oncology. 15. 1550917–1550917.
3.
Wu, Hong, Yiqiang Liu, Zhaoshen Li, et al.. (2024). HMMR triggers immune evasion of hepatocellular carcinoma by inactivation of phagocyte killing. Science Advances. 10(23). eadl6083–eadl6083. 8 indexed citations
4.
Hu, Lanlin, Mingxin Liu, Bo Tang, et al.. (2024). PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3. Cancer Gene Therapy. 31(11). 1696–1707. 1 indexed citations
5.
Yang, Rui, et al.. (2024). Cancer stem cells: a target for overcoming therapeutic resistance and relapse. Cancer Biology and Medicine. 20(12). 985–1020. 13 indexed citations
6.
7.
Hu, Lanlin, Mingxin Liu, Bo Tang, et al.. (2023). Posttranslational regulation of liver kinase B1 in human cancer. Journal of Biological Chemistry. 299(4). 104570–104570. 9 indexed citations
8.
Li, Yunchang, et al.. (2022). Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer. Cancer Drug Resistance. 5(1). 129–146. 9 indexed citations
9.
Zhang, Tao, Lili Zhao, Liping Han, et al.. (2022). TRX2/Rab35 Interaction Impairs Exosome Secretion by Inducing Rab35 Degradation. International Journal of Molecular Sciences. 23(12). 6557–6557. 7 indexed citations
10.
Tang, Bo, Lanlin Hu, Yunchang Li, et al.. (2022). A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma. International Journal of Molecular Sciences. 23(20). 12143–12143. 10 indexed citations
11.
Shi, Ying, Mengwan Wu, Yuyang Liu, et al.. (2021). ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma. Frontiers in Oncology. 11. 769592–769592. 17 indexed citations
12.
Hu, Lanlin, Yutong Liang, Caixia Wang, et al.. (2021). Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells. Annals of Translational Medicine. 9(2). 114–114. 12 indexed citations
13.
Li, Yunchang, Lanlin Hu, & Chuan Xu. (2021). Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer. Current Opinion in Oncology. 34(1). 66–76. 2 indexed citations
14.
Bhola, Neil E., et al.. (2021). PD‐L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance. Head & Neck. 43(11). 3364–3373. 11 indexed citations
15.
Wang, Chao, Rui Peng, Shengpeng Liu, et al.. (2020). Cellular and molecular responses-mediated by DjMEK1/2 are necessary for planarian regeneration. International Journal of Biological Macromolecules. 164. 3751–3761. 6 indexed citations
16.
Hu, Lanlin, et al.. (2019). Gene targets of sulforaphane in head and neck squamous cell carcinoma. Molecular Medicine Reports. 20(6). 5335–5344. 9 indexed citations
17.
Hill, Alison L., et al.. (2015). Predicting determinants of long-term HIV control with gene therapy strategies. Journal of Virus Eradication. 1. 41–41. 1 indexed citations
18.
Hu, Lanlin, et al.. (2014). Complete mitochondrial genome of the Pallas’s squirrel Callosciurus erythraeus (Rodentia: Sciuridae). Mitochondrial DNA Part A. 27(3). 1850–1851. 3 indexed citations
19.
Honer, William G., Peter Falkai, Clint Young, et al.. (1997). Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience. 78(1). 99–110. 129 indexed citations
20.
Gong, Yun Yun, Lanlin Hu, & De-Chang Wu. (1992). Effect of 60Co gamma-irradiation on the nonspecific cytotoxicity of alveolar macrophages in vitro.. Environmental Health Perspectives. 97. 167–170. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birgit Nimmervoll Breakdown of academic impact, for papers by Simon April-Monn Breakdown of academic impact, for papers by John R. Jacob Breakdown of academic impact, for papers by Hyun–Taek Kim Breakdown of academic impact, for papers by Carmela Gómez Breakdown of academic impact, for papers by Fernando C. Alsina Breakdown of academic impact, for papers by Razina Aziz‐Bose Breakdown of academic impact, for papers by Yasuharu Takamori Breakdown of academic impact, for papers by Ilona Kondratiuk Breakdown of academic impact, for papers by Yi Tan
Rankless by CCL
2026